Medicus Pharma (MDCX) Change in Account Payables (2024 - 2025)
Medicus Pharma (MDCX) reported Change in Account Payables of -$26604.0 for Q4 2025, down 104.64% on a YoY basis from $572989.0 in Q4 2024, and down 222.0% quarter-over-quarter from $21807.0 in Q3 2025.
Medicus Pharma (MDCX) Change in Account Payables (2024 - 2025) Analysis & Trends
Medicus Pharma has reported Change in Account Payables for 2 years, with the latest figure at -$26604.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 104.64% year-over-year to -$26604.0; the trailing twelve-month figure through Dec 2025 stood at -$25983.0 (down 103.21% YoY), and the FY2025 full-year result was -$25983.0, down 103.21% from the prior year.
- Change in Account Payables for Q4 2025 stood at -$26604.0, down from $21807.0 in the prior quarter.
- The five-year high for Change in Account Payables was $572989.0 in Q4 2024, with the low at -$78116.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | - |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | - |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 571.00 Mn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | -67.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 409.00 Mn |
| 10 | Medicus Pharma | 7.87 Mn | 7.98 Mn | - | -26,604.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26,604.00 |
| Dec 31, 2025 | -26,604.00 |
| Sep 30, 2025 | 21,807.00 |
| Sep 30, 2025 | 21,807.00 |
| Jun 30, 2025 | 3,058.00 |
| Jun 30, 2025 | 3,058.00 |
| Mar 31, 2025 | -24,244.00 |
| Mar 31, 2025 | -24,244.00 |
| Dec 31, 2024 | 572,989.00 |
| Dec 31, 2024 | 572,989.00 |
| Sep 30, 2024 | 266,606.00 |
| Sep 30, 2024 | 266,606.00 |
| Jun 30, 2024 | -78,116.00 |
| Jun 30, 2024 | -78,116.00 |
| Mar 31, 2024 | 47,266.00 |
| Mar 31, 2024 | 47,266.00 |